Rise and Shine: What you need to know before the ASX opens
Link copied to
On Stockhead today, all about yesterday’s red-letter day for greenlit clinical trials, Animoca catches the eye of a Silicon Valley whale, and the education election promises that will affect ASX stocks.
But first, here’s what you need to know about the day ahead.
Tuesday sees the Australian Bureau of Statistics go to work with retail sales data as well as import and export data, while the RBA hands down its monthly rate decision. It has not moved from its current 1.5 per cent level since August 2016, an unprecedented period of no change.
This time around, there is some noise that the RBA may cut the rate to 1.25 per cent, which would be a new record low. There has not been an increase in nearly a decade.
Just one company with shares out of escrow today:
The following 11 companies are due out of a trading halt in the next 48 hours:
Gold: $US1281.31 ($1,831.25) +0.11%
Silver: $US14.86 -0.17%
Oil (Brent): $US71.36 +0.92%
Oil (WTI): $US62.62 +1.13%
Coal: $US88.95 -0.84%
Iron ore 62pc fe: $US93.81 +0.22%
Want this headstart in your inbox every morning at 8am? Go on. Subscribe here. It’s free
New member Nathan Lee was generating some chat with his hello post on the Stockhead Facebook chat forum.
“Hello everyone. I’m a young investor who is looking to invest a couple of thousand dollars into shares. Any recommendations would be much appreciated 🙂 I am looking for long-term growth shares and I have a shortlist however I have been unable to build up enough courage to invest in them yet.”
If you’ve got some advice for Nathan, or looking for advice yourself, jump on the forum and join up!
These were the five most-discussed stocks on trading gossip forum HotCopper at close on Monday:
— HotCopper (@HotCopper) May 6, 2019
Brickworks will supply bespoke bricks for FBR exclusively in Australia, and FBR will be the exclusive user for an initial three-year period.
Not a surprise for Bubs Australia (ASX:BUB), either, whose shares have once again hit a new all-time high after launching a new range of organic, grass-fed cattle milk infant formula.
They closed up 11 per cent to $1.48.
There were plenty of movers on little news yesterday, however shares in ImpediMed (ASX:IPD) dropped 21 per cent to 21c after its PREVENT trial failed to produce results of statistical significance.
That’s all you need to know. Jump in.